title: Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE).
abstract: OBJECTIVE
  A group of UK consultant transplant physicians and surgeons (the Consensus Group) met to consider the implications and interpretation of the National Institute for Clinical Excellence's (NICE) Technology Appraisal No. 85 on the use of immunosuppressive therapy for renal transplantation in adults.
  
  
  METHODS
  This group considered what the implications of these guidelines might be for clinical practice and consensus was developed on those areas which were potentially open to different interpretations. A wider survey of nephrologists and transplant surgeons throughout the UK was also performed to gauge the impact of the NICE recommendations.
  
  
  CONCLUSIONS
  The outcome of the discussions of the Consensus Group are presented with particular reference to the recommendations of how to respond to calcineurin inhibitor (CNI) intolerance. The survey suggested that the publication of this NICE guidance has resulted in relatively few changes in prescribing practice: UK transplant centers continue to use a wide range of locally developed protocols for immunosuppressive therapy. These include the use of agents such as mycophenolate mofetil (MMF) and sirolimus, despite the fact that both drugs appeared to receive only conditional acceptance in the NICE Guidelines.
authors.affiliation: Department of Immunology and Renal Medicine, Imperial College London, Hammersmith Campus, London, UK. a.warrens@imperial.ac.uk
authors.forename: A N
authors.initials: AN
authors.lastname: Warrens
authors.forename: K
authors.initials: K
authors.lastname: Baboolal
authors.forename: L
authors.initials: L
authors.lastname: Buist
authors.forename: C
authors.initials: C
authors.lastname: Dudley
authors.forename: G
authors.initials: G
authors.lastname: Koffman
authors.forename: G
authors.initials: G
authors.lastname: Lipkin
authors.forename: N
authors.initials: N
authors.lastname: Parrott
authors.forename: S H
authors.initials: SH
authors.lastname: Powis
authors.forename: P
authors.initials: P
authors.lastname: Sweny
authors.forename: M
authors.initials: M
authors.lastname: Raftery
mesh_terms: D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D017410:Practice Guidelines as Topic; D012017:Referral and Consultation / Q000592:standards*; D006113:United Kingdom
chemical_list: D007166:Immunosuppressive Agents